Clinical Trials of Broadly Neutralizing Monoclonal Antibodies for Human Immunodeficiency Virus Prevention: A Review

Journal of Infectious Diseases
Volume 223, Issue 3, 1 February 2021
https://academic.oup.com/jid/issue/223/3

 

REVIEWS
Clinical Trials of Broadly Neutralizing Monoclonal Antibodies for Human Immunodeficiency Virus Prevention: A Review
Sharana Mahomed, Nigel Garrett, Cheryl Baxter, Quarraisha Abdool Karim, Salim S Abdool Karim
The Journal of Infectious Diseases, Volume 223, Issue 3, 1 February 2021, Pages 370–380, https://doi.org/10.1093/infdis/jiaa377
The use of broadly neutralizing antibodies (bnAbs) is a promising approach that could help reduce the human immunodeficiency virus (HIV) epidemic burden. This review describes the status and available data on bnAbs in clinical trials for HIV prevention.